Jane Street’s Heron Therapeutics HRTX Stock Holding History

Jane Street’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29,200	Closed	-$167K	–	10133
2022 Q1	$167K	Sell	29,200 -90,300	-76%	-$661K	﹤0.01%	9151
2021 Q4	$1.09M	Buy	119,500 +98,100	+458%	+$1M	﹤0.01%	5714
2021 Q3	$229K	Sell	21,400 -7,000	-25%	-$85.2K	﹤0.01%	8652
2021 Q2	$441K	Buy	28,400 +10,200	+56%	+$162K	﹤0.01%	7474
2021 Q1	$295K	Buy	+18,200	New	+$324K	﹤0.01%	7729
2020 Q4	–	Sell	-11,800	Closed	-$175K	–	7733
2020 Q3	$175K	Sell	11,800 -33,000	-74%	-$515K	﹤0.01%	6510
2020 Q2	$659K	Buy	+44,800	New	+$736K	﹤0.01%	4661

Other funds holding HRTX

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Jane Street's HRTX Position: Q2 2026 in Review

Jane Street opened a new position in Heron Therapeutics (HRTX) in Q2 2026: 25,672 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #11295 among its holdings. This is a return to the name: Jane Street previously reported a position in HRTX as recently as Q4 2025.

Jane Street first reported a position in HRTX in Q1 2014 and has held it in 36 quarters since. The position peaked at $1.78M in Q4 2025. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

Jane Street held 25,672 shares of Heron Therapeutics worth $11K as of Q2 2026.
Heron Therapeutics was a new Jane Street position in Q2 2026.
Heron Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11295 holding.
Jane Street first reported a position in Heron Therapeutics in Q1 2014 and has held it in 36 quarters since.
Jane Street's Heron Therapeutics position peaked at $1.78M in Q4 2025.
163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.